ResearcherThomas Jefferson UniversityNo recent work listed
Theresa Pluth Yeo
Matched on ORCID iD 0009-0003-4402-6114; OpenAlex author ID A5034438317. Sources: ClinicalTrials.gov.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2009: 1 trial · 2010: none · 2011: none · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 3 papers · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper
Papers 8
- Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancrea… Co-author DOI 10.1136/bmjopen-2023-073839↗
- Optimizing cancer cure dialog: an analysis of pancreatic cancer patients' views regarding survival and cure. Co-author DOI 10.1007/s00520-019-05214-0↗
- Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progression. Co-author DOI 10.1016/j.jamcollsurg.2019.12.033↗
- A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2. Co-author DOI 10.1016/j.jamcollsurg.2017.12.052↗
- Pancreatic Cancer-Associated Depression: A Case Report and Review of the Literature. First author DOI 10.1097/mpa.0000000000001148↗
- Symptom Clusters in Patients With Pancreatic Cancer Undergoing Surgical Resection: Part I. First author DOI 10.1188/18.onf.e36-e52↗
- Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma. Co-author DOI 10.1053/j.seminoncol.2014.12.002↗
- Demographics and epidemiology of pancreatic cancer. Co-author DOI 10.1097/ppo.0b013e3182756803↗
Trials 1
- Fatigue and Pancreas and Bile Duct Cancer Study Principal investigator NCT00902759↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Harish Lavu · 5 shared papers, 2018–2023 · strength 0.57
- Paper Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase… DOI 10.1136/bmjopen-2023-073839↗
- Paper Optimizing cancer cure dialog: an analysis of pancreatic cancer patients' views regarding survival and cure. DOI 10.1007/s00520-019-05214-0↗
- Paper Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progres… DOI 10.1016/j.jamcollsurg.2019.12.033↗
- Charles J. Yeo · 5 shared papers, 2018–2023 · strength 0.57
- Paper Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase… DOI 10.1136/bmjopen-2023-073839↗
- Paper Optimizing cancer cure dialog: an analysis of pancreatic cancer patients' views regarding survival and cure. DOI 10.1007/s00520-019-05214-0↗
- Paper Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progres… DOI 10.1016/j.jamcollsurg.2019.12.033↗
- Avinoam Nevler · 4 shared papers, 2018–2023 · strength 0.48
- Paper Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase… DOI 10.1136/bmjopen-2023-073839↗
- Paper Optimizing cancer cure dialog: an analysis of pancreatic cancer patients' views regarding survival and cure. DOI 10.1007/s00520-019-05214-0↗
- Paper Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progres… DOI 10.1016/j.jamcollsurg.2019.12.033↗
- Jonathan Robert Brody · 3 shared papers, 2018–2023 · strength 0.35
- Paper Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase… DOI 10.1136/bmjopen-2023-073839↗
- Paper Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progres… DOI 10.1016/j.jamcollsurg.2019.12.033↗
- Paper A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,… DOI 10.1016/j.jamcollsurg.2017.12.052↗
- Jordan Michael Winter · 3 shared papers, 2018–2020 · strength 0.31
- Paper Optimizing cancer cure dialog: an analysis of pancreatic cancer patients' views regarding survival and cure. DOI 10.1007/s00520-019-05214-0↗
- Paper Pancreatic Cancer-Associated Depression: A Case Report and Review of the Literature. DOI 10.1097/mpa.0000000000001148↗
- Paper A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,… DOI 10.1016/j.jamcollsurg.2017.12.052↗
- Christopher William Schultz · 2 shared papers, 2020–2023 · strength 0.27
- Paper Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase… DOI 10.1136/bmjopen-2023-073839↗
- Paper Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progres… DOI 10.1016/j.jamcollsurg.2019.12.033↗
- Francesca Ponzini · 1 shared paper, 2023 · strength 0.17
- James A. Posey · 1 shared paper, 2023 · strength 0.17
- Scott W. Keith · 1 shared paper, 2020 · strength 0.13
- Adam F. Barnes · 1 shared paper, 2018 · strength 0.11
- David O. Nauheim · 1 shared paper, 2020 · strength 0.10
- Samantha Z. Brown · 1 shared paper, 2020 · strength 0.10
- Grace A. McCarthy · 1 shared paper, 2020 · strength 0.10
- Sherry A. Burrell · 1 shared paper, 2018 · strength 0.09
- George C Prendergast · 1 shared paper, 2018 · strength 0.08
- Albert B. Lowenfels · 1 shared paper, 2012 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.